Congress Chairs

Dr. Silviu Brill
Tel Aviv Medical Center, Israel

Dr. Silviu Brill is Specialist in Anesthesiology and Pain Management, Director of the Institute for Pain Medicine, Tel Aviv Medical Center, Israel.

Past President of the Israeli Pain Association and Past President, Pain Section of the Israeli Society of Anesthesiology,
Co-Chair of the Scientific Council Pain Residency Exam, Scientific Council, Israel Medical Association.
Reviewer for: Anesthesia & Analgesia, Clinical Orthopaedics & Related Research Journal, Harefua, European Journal of Pain and for Chief Scientist Office, Ministry of Health.

He is member of Committee on Education and member of the Task force on Cannabis based medicine of EFIC.

His main research interest is Neuromodulation, Psychologic aspects of Chronic Pain postsurgical neuropathic pain and Medical use of Cannabinoids.

Dr. Brill received grants from European Union for Development of an International Pain Registry-Pain-Out, British Chevening Medical Scholarship, Israel Science Foundation, Israel Pain Association and The Israel Cancer Association. Dr. Silviu Brill is Specialist in Anesthesiology and Pain Management, Director of the Institute for Pain Medicine, Tel Aviv Medical Center, Israel.

Prof. David Finn
University of Galway, Ireland

Prof. David Finn is Professor of Pharmacology and Therapeutics, Principal Investigator and Founding Co-Director of the Centre for Pain Research at the University of Galway.  Prof. Finn graduated with a BSc (Hons) in Biotechnology from University of Galway and a PhD in Neuroscience from the University of Bristol, after which he worked as a Post-doctoral Research Fellow at the Institute of Neuroscience, University of Nottingham.

Prof. Finn’s research focuses on the affective and cognitive dimensions of pain, stress-pain interactions, and neuroinflammatory processes, with an emphasis on the endogenous cannabinoid, opioid and monoaminergic systems.  Prof. Finn is Past-President of the Irish Pain Society and is currently President of the International Cannabinoid Research Society.  He is also a member of the Task Forces of both the International Association for the Study of Pain and the European Pain Federation on Cannabis and Cannabinoids for Chronic Pain, and he sits on the Scientific Advisory Panel of the European College of Neuropsychopharmacology as well as the Editorial Boards of the Journal of Psychopharmacology, Brain Research and Frontiers in Neuropharmacology.

Prof. Finn has published over 140 peer reviewed papers or book chapters and is regularly invited to speak at national and international conferences.